Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121313933 | 12131393 | 3 | F | 2012 | 20160830 | 20160301 | 20160906 | EXP | CA-PFIZER INC-2016118176 | PFIZER | 50.00 | YR | F | Y | 0.00000 | 20160906 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121313933 | 12131393 | 1 | PS | CELEBREX | CELECOXIB | 1 | Oral | 200 MG, 2X/DAY | N | 20998 | 200 | MG | CAPSULE, HARD | BID | |||||
| 121313933 | 12131393 | 2 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Subcutaneous | 0.8 ML, WEEKLY INJECTION | N | 11719 | .8 | ML | SOLUTION FOR INJECTION | /wk | |||||
| 121313933 | 12131393 | 3 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Oral | 1000 MG (2X 500 MG TABLETS), 2X/DAY | N | 7073 | 1000 | MG | TABLET | BID | |||||
| 121313933 | 12131393 | 4 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Oral | UNK | N | 7073 | TABLET | ||||||||
| 121313933 | 12131393 | 5 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Oral | 400 MG, 2X/DAY: 2 TABLETS TWICE DAILY | N | 0 | 400 | MG | TABLET | BID | |||||
| 121313933 | 12131393 | 6 | SS | PREDNISONE. | PREDNISONE | 1 | DOSE CHANGED OVER YEARS | 0 | |||||||||||
| 121313933 | 12131393 | 7 | SS | PREDNISONE. | PREDNISONE | 1 | Oral | 20 MG, DAILY FOR TWO WEEKS AT WHICH TIME SHE WILL START WEANING | 0 | 20 | MG | ||||||||
| 121313933 | 12131393 | 8 | SS | ACTEMRA | TOCILIZUMAB | 1 | UNK | N | 0 | ||||||||||
| 121313933 | 12131393 | 9 | SS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | UNK | N | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121313933 | 12131393 | 1 | Rheumatoid arthritis |
| 121313933 | 12131393 | 2 | Rheumatoid arthritis |
| 121313933 | 12131393 | 3 | Rheumatoid arthritis |
| 121313933 | 12131393 | 5 | Rheumatoid arthritis |
| 121313933 | 12131393 | 6 | Rheumatoid arthritis |
| 121313933 | 12131393 | 8 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121313933 | 12131393 | HO |
| 121313933 | 12131393 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121313933 | 12131393 | Condition aggravated | |
| 121313933 | 12131393 | Diverticulitis | |
| 121313933 | 12131393 | Drug ineffective | |
| 121313933 | 12131393 | Dyspnoea | |
| 121313933 | 12131393 | Hernia | |
| 121313933 | 12131393 | Joint destruction | |
| 121313933 | 12131393 | Nausea | |
| 121313933 | 12131393 | Rheumatoid arthritis | |
| 121313933 | 12131393 | Stoma complication |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121313933 | 12131393 | 1 | 2012 | 0 | ||
| 121313933 | 12131393 | 2 | 2012 | 0 | ||
| 121313933 | 12131393 | 3 | 2012 | 0 | ||
| 121313933 | 12131393 | 4 | 201406 | 201411 | 0 | |
| 121313933 | 12131393 | 7 | 20160222 | 0 | ||
| 121313933 | 12131393 | 8 | 2012 | 0 | ||
| 121313933 | 12131393 | 9 | 201401 | 201406 | 0 |